Glycostasis, Inc. — Form D

Glycostasis, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-11. The offering totals $2.7M, of which $150K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2015-06-11
• Form: D
• Accession: 0001644472-15-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.7M
• Amount sold: $150K
• Remaining: $2.5M
• Investors: 1
• Date of first sale: 2015-05-28
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-241544

Issuer

• Name: Glycostasis, Inc.
• CIK: 0001644472
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2012
• Address: 4317 DENSMORE AVE. N., SEATTLE, WA, 98103
• Phone: 425-591-9641

Officers, directors & promoters (3)

More

• CIK 1644472 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search